Compounds > zm 241385
Page last updated: 2024-09-05

zm 241385 and Parkinson Disease

zm 241385 has been researched along with Parkinson Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ayyub, E; Chang, HX; Dowling, JE; Engber, T; Haque, S; Jin, X; Kumaravel, G; Petter, RC; Phadke, D; van Vloten, K; Vessels, JT; Wang, J1
Byeon, JJ; Choi, JM; Kim, N; Lee, BI; Lim, JH; Na, YG; Park, MH; Park, MJ; Park, SJ; Park, Y; Shin, SH; Shin, YG1
Bencivelli, D; Borea, PA; Casetta, I; Corciulo, C; Gentile, M; Granieri, E; Varani, K; Vincenzi, F1
Che, PL; Du, J; Ha, B; Wang, Z; Yarema, KJ1
Chancellor, MB; de Groat, WC; Kitta, T; Kuno, S; Nonomura, K; Yoshimura, N1

Other Studies

5 other study(ies) available for zm 241385 and Parkinson Disease

ArticleYear
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2005, Nov-01, Volume: 15, Issue:21

    Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Cell Membrane; Disease Models, Animal; Parkinson Disease; Pyrazines; Radioligand Assay; Rats; Structure-Activity Relationship

2005
In Vitro, In Silico, and In Vivo Assessments of Pharmacokinetic Properties of ZM241385.
    Molecules (Basel, Switzerland), 2020, Mar-02, Volume: 25, Issue:5

    Topics: Adenosine A2 Receptor Antagonists; Animals; Computer Simulation; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Triazines; Triazoles

2020
A(2A) adenosine receptors and Parkinson's disease severity.
    Acta neurologica Scandinavica, 2014, Volume: 129, Issue:4

    Topics: Adenosine A2 Receptor Agonists; Aged; Disease Progression; Dose-Response Relationship, Drug; Dyskinesias; Female; Humans; Lymphocytes; Male; Middle Aged; Parkinson Disease; Protein Binding; Receptor, Adenosine A2A; Statistics, Nonparametric; Triazines; Triazoles; Tritium

2014
Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385.
    PloS one, 2010, Nov-08, Volume: 5, Issue:11

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analysis of Variance; Animals; Blotting, Western; Calcium; Cell Proliferation; Cyclic AMP; Iron; Magnetic Field Therapy; Magnetics; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurites; Parkinson Disease; PC12 Cells; Phenethylamines; Phosphorylation; Rats; Receptor, Adenosine A2A; Triazines; Triazoles

2010
Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease.
    The Journal of urology, 2012, Volume: 187, Issue:5

    Topics: Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Parkinson Disease; Rats; Rats, Sprague-Dawley; Triazines; Triazoles; Urinary Bladder, Overactive; Urination

2012